Clinical Trial Update: Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma [NA]

View source ↗

Summary

Clinical trial update indicating the study evaluating Velcade (bortezomib), Doxil (liposomal doxorubicin), and dexamethasone (VDd) in multiple myeloma has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Doxil (liposomal doxorubicin)
• Velcade (bortezomib)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Multiple Myeloma | NA | Status: COMPLETED